A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy with or Without Veliparib in Stage III Non–small-cell Lung Cancer: SWOG 1206 (8811)

Athanassios Argiris,Jieling Miao,Mihaela C. Cristea,Allen M. Chen,Jacob M. Sands,Roy H. Decker,Scott N. Gettinger,Megan E. Daly,Bryan A. Faller,Kathy S. Albain,Ronald H. Yanagihara,Linda L. Garland,Lauren A. Byers,Ding Wang,Marianna Koczywas,Mary W. Redman,Karen Kelly,David R. Gandara

Clinical lung cancer（2021）

引用 11|浏览12

暂无评分

关键词

NSCLC,Thoracic radiotherapy,PARP inhibitors,carboplatin,paclitaxel

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要